# $nktr

Nektar Therapeutics faces ongoing legal battles with Eli Lilly, with a jury trial set for September 8, 2026, creating significant uncertainty. Meanwhile, positive sentiment surrounds its clinical data and pipeline potential, particularly in dermatology.

### About $nktr
Nektar Therapeutics is a biotechnology company focused on developing innovative therapies.  

### Insights
- $nktr sentiment is up 47.27% from the previous month.
- $nktr engagements is up 128.78% from the previous week.

### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [------] +129%  
[--] Month: [---------] -44%  
[--] Months: [----------] +46%  
[--] Year: [----------] +1,950%  
1-Year High: [---------] on 2025-06-24  
1-Year Low: [---] on 2025-04-08  

Engagements by network (24h):
Reddit: [--]
YouTube: [--]
X: [------]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Month: [---] +100%  
1-Year High: [-----] on 2025-06-25  
1-Year Low: [--] on 2025-05-27  

Mentions by network (24h):
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $nktr in the last [--] hours which is up 15% from [--] in the previous [--] hours
Daily Average: [---]  
[--] Month: [--] +56%  
1-Year High: [-----] on 2025-06-25  
1-Year Low: [--] on 2025-05-24  

The most influential creators that mention $nktr in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]    | [------]      |
| [@A_May_MD](/creator/twitter/A_May_MD)               | [--]    | [------]    | [--]    | [------]      |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | [--]    | [-----]     | [--]     | [-----]       |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]    | [-----]       |
| [@Taintslapp12283](/creator/twitter/Taintslapp12283) | [--]    | [---]       | [--]     | [-----]       |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | [--]    | [------]    | [--]     | [-----]       |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | [--]    | [-----]     | [--]    | [-----]       |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [-----]     | [--]     | [-----]       |
| [@BornInvestor](/creator/twitter/BornInvestor)       | [--]    | [------]    | [--]     | [-----]       |
| [@adamfeuerstein](/creator/twitter/adamfeuerstein)   | [--]   | [-------]   | [--]     | [-----]       |

[View More](/list/creators/$nktr/100)
  
  
### Sentiment: 79%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/sentiment.tsv)  
Current Value: 79%  
Daily Average: 81%  
[--] Week: 100% +29%  
[--] Month: 81% +26%  
[--] Months: 81% +3%  
[--] Year: 81% -19%  
1-Year High: 100% on 2025-02-14  
1-Year Low: 33% on 2025-03-31  

Most Supportive Themes:
- Positive Stock Performance and Analyst Confidence: (40%) Multiple posts highlight Nektar's (NKTR) recent stock performance, with some noting significant gains since previous pitches. Analysts express confidence in the company's valuation and future potential, even comparing it favorably to competitors.
- Clinical Data and Pipeline Potential: (30%) Discussions revolve around Nektar's clinical data, particularly in dermatology, with comparisons to competitor drugs like Dupixent. The potential for dual indications and efficient P3 studies is seen as a significant tailwind.
- Strategic Moves and Executive Changes: (20%) Posts mention Nektar's ongoing legal situations and recent executive changes, such as the Chief Legal Officer's departure and subsequent move to Septerna. These events are noted in the context of the company's broader strategic landscape.
  
Most Critical Themes:
- Legal Battles and Uncertainty: (70%) Nektar's legal proceedings, particularly with Eli Lilly (LLY), are a recurring theme, creating an undercurrent of uncertainty. The resolution of these cases is seen as a key factor influencing the stock's trajectory.
- Competitive Landscape and Alternative Investments: (30%) Some posts suggest alternative investment opportunities or compare Nektar unfavorably to competitors, indicating that the market may be overlooking other promising biotech plays. This highlights the competitive nature of the sector.
  

### Top $nktr Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"We're going UPPP $IRTC $ACHL $PTGX $KRYS $TGTX $PRVB $RXRX $AMRN $IRWD $URGN $RPTX $SAGE $ARWR $VACC $TWST $FOLD $MRTX $VERA $MIRM $IOVA $ABS $PRDS $RAPT $ODT $CTMX $PTPI $FREQ $PMVP $BPMC $UBX $GRTS $FRLN $ELDN $QURE $IDRA $CGON $NKTR $RIGL $NRRSF $NOM Norsemont Mining Breakout Brewing 🚨 NRRSF is flashing a clean reversal setup after reclaiming long-term resistance and holding rising trendline support. 📊 Key Levels * Support: $0.75$0.80 * Pivot: $0.85$0.90 * Major Resistance: $1.00 * Targets: $1.20$1.40 https://t.co/W2T6nwpnkN $NRRSF $NOM Norsemont Mining Breakout Brewing 🚨 NRRSF is"  
[X Link](https://x.com/mariostario2019/status/2019798905823637939) [@mariostario2019](/creator/x/mariostario2019) 2026-02-06T15:42Z [--] followers, [---] engagements


"The biotech / pharma / medtech stocks I currently hold: $ELTX $ABVX $QURE $RVMD $NKTR $KYMR $DERM $PALI $CMOPF $VSTM $BBOT $PRME $CLPT This list is in no particular order"  
[X Link](https://x.com/chaotropy/status/2019786173376332209) [@chaotropy](/creator/x/chaotropy) 2026-02-06T14:52Z [---] followers, [----] engagements


"🚨 miR-155 may be compelling NEW mechanistic biomarker to add to biomarkers tracked for atopic dermatitis #asthma allergic rhinitis etc $ACRS $APGE $CRVS $EVMN $KYMR $NKTR Key Biomarkers followed for Type [--] Diseases like AD: see slides from $KYMR + $CRVS showing some of them [--]. TARC/CCL17 remains the most validated single serum biomarker for AD severity. #TARC as a chemokine identifies/controls how Th2 cells are trafficked to skin for inflammation. Lower levels of TARC typically correspond w/ disease control. However this single biomarker is insufficient on its own to replace clinical scoring"  
[X Link](https://x.com/HOThomasWPhelps/status/2019655545691533463) [@HOThomasWPhelps](/creator/x/HOThomasWPhelps) 2026-02-06T06:13Z [----] followers, [----] engagements


"$NKTR vs $LLY who you got ORDER. A pretrial conference is set for August [--] [----] at 1:30PM in San Francisco Courtroom [--] 19th Floor. A jury trial is set for September [--] [----] at 9AM in San Francisco Courtroom [--]. The parties are advised that each side will have [--] hours exclusive of openings and closings to present their case. Signed by Judge James Donato on 02/05/2026. https://twitter.com/i/web/status/2019566495798349964 https://twitter.com/i/web/status/2019566495798349964"  
[X Link](https://x.com/EggCapitalWS/status/2019566495798349964) [@EggCapitalWS](/creator/x/EggCapitalWS) 2026-02-06T00:19Z [---] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing